Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Utility of FDG-PET for Investigating Unexplained Serum AFP Elevation in Patients with Suspected Hepatocellular Carcinoma Recurrence

YEN-KUNG CHEN, DAR-SHIH HSIEH, CHAO-SHENG LIAO, CHYI-HUEY BAI, CHEN-TAU SU, YEH-YOU SHEN, JIH-FANG HSIEH, ALFRED C. LIAO and CHIA-HUNG KAO
Anticancer Research November 2005, 25 (6C) 4719-4725;
YEN-KUNG CHEN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DAR-SHIH HSIEH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHAO-SHENG LIAO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHYI-HUEY BAI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHEN-TAU SU
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YEH-YOU SHEN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JIH-FANG HSIEH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ALFRED C. LIAO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHIA-HUNG KAO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: d10040{at}www.cmuh.org.tw
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

The aim of this study was to evaluate the potential role of positron emission tomography (PET) with 18F-fluorodeoxyglucose (FDG) in patients with unexplained rising serum alpha-fetoprotein (AFP) levels after the treatment of hepatocellular carcinoma (HCC). Patients and Methods: Thirty-one FDG-PET studies were performed in 26 patients (age range, 45-83; 21 men and 5 women), who had undergone either surgical resection or interventional therapy for HCC, but were subsequently noted to have high AFP serum levels on routine follow-up examinations, although imaging studies and physical examinations were normal. The FDG-PET results were correlated with histological findings, as well as long-term radiological and clinical follow-up (shortest follow-up period after FDG-PET was 6 months). Results: FDG-PET was abnormal in 22 of the 31 studies (71.0%) among the 26 patients. Intrahepatic lesions were detected in 20 of a total 30 lesions (66.7%) in 18 studies of FDG-PET among 26 patients. Ten FDG-PET studies among 9 patients identified one intrahepatic lesion, while 3 studies among 3 patients identified more than one intrahepatic lesion. Extrahepatic metastases were found in 9/31 studies of FDG-PET (29.0%) among 8 patients. These metastatic foci, composed of increased FDG accumulation, were identified in several locations; lung (4 studies among 4 patients), bone (2 studies among 2 patients) and the peritoneum (4 studies among 3 patients). Overall, FDG-PET for detecting HCC recurrence demonstrated 22 true-positives, 8 false-negatives, 1 true-negative and 0 false-positive results. The sensitivity, specificity and accuracy of FDG-PET for detecting HCC recurrence was 73.3%, 100% and 74.2%, respectively. Conclusion: When conventional examinations are normal, FDG-PET is a valuable imaging tool in patients who have rising AFP levels after HCC treatment. FDG-PET whole-body scan also provides an important and valuable imaging study for detecting extrahepatic metastasis.

  • Positron emission tomography
  • 18F-fluorodeoxyglucose
  • hepatocellular carcinoma
  • alpha-fetoprotein

Footnotes

  • Received May 20, 2005.
  • Accepted July 7, 2005.
  • Copyright© 2005 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved
PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 25, Issue 6C
1 Nov 2005
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Utility of FDG-PET for Investigating Unexplained Serum AFP Elevation in Patients with Suspected Hepatocellular Carcinoma Recurrence
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
4 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Utility of FDG-PET for Investigating Unexplained Serum AFP Elevation in Patients with Suspected Hepatocellular Carcinoma Recurrence
YEN-KUNG CHEN, DAR-SHIH HSIEH, CHAO-SHENG LIAO, CHYI-HUEY BAI, CHEN-TAU SU, YEH-YOU SHEN, JIH-FANG HSIEH, ALFRED C. LIAO, CHIA-HUNG KAO
Anticancer Research Nov 2005, 25 (6C) 4719-4725;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Utility of FDG-PET for Investigating Unexplained Serum AFP Elevation in Patients with Suspected Hepatocellular Carcinoma Recurrence
YEN-KUNG CHEN, DAR-SHIH HSIEH, CHAO-SHENG LIAO, CHYI-HUEY BAI, CHEN-TAU SU, YEH-YOU SHEN, JIH-FANG HSIEH, ALFRED C. LIAO, CHIA-HUNG KAO
Anticancer Research Nov 2005, 25 (6C) 4719-4725;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Evaluation of Metabolic Characteristics and Viability of Lipiodolized Hepatocellular Carcinomas Using 18F-FDG PET/CT
  • Detection of Hepatocellular Carcinoma with PET/CT: A Prospective Comparison of 18F-Fluorocholine and 18F-FDG in Patients with Cirrhosis or Chronic Liver Disease
  • NCCN Task Force: Clinical Utility of PET in a Variety of Tumor Types
  • A Prospective Evaluation of 18F-FDG and 11C-Acetate PET/CT for Detection of Primary and Metastatic Hepatocellular Carcinoma
  • Dual-Tracer PET/CT Imaging in Evaluation of Metastatic Hepatocellular Carcinoma
  • Google Scholar

More in this TOC Section

  • Potential of Inflammatory and Nutritional Markers and Clinicopathological Factors for Prognostic Prediction in Osteosarcoma
  • Diameter of IPDA Is Associated With Maintenance of Hepatic Arterial Blood Flow in DP-CAR
  • Postoperative Changes in Nutritional Status and their Impact on Post-recurrence Prognosis After Pancreatoduodenectomy in Patients With Biliary Tract Carcinoma: An Age-stratified Analysis
Show more Clinical Studies
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire